| Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients T Bjarnsholt, PØ Jensen, MJ Fiandaca, J Pedersen, CR Hansen, ... Pediatric pulmonology 44 (6), 547-558, 2009 | 940 | 2009 |
| Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis P Garred, T Pressler, HO Madsen, B Frederiksen, A Svejgaard, N Høiby, ... The Journal of clinical investigation 104 (4), 431-437, 1999 | 588 | 1999 |
| Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium JM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, ... Science 354 (6313), 751-757, 2016 | 527 | 2016 |
| Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa PØ Jensen, T Bjarnsholt, R Phipps, TB Rasmussen, H Calum, ... Microbiology 153 (5), 1329-1338, 2007 | 492 | 2007 |
| Occurrence of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation O Ciofu, B Riis, T Pressler, HE Poulsen, N Høiby Antimicrobial agents and chemotherapy 49 (6), 2276-2282, 2005 | 346 | 2005 |
| Eradication of early Pseudomonas aeruginosa infection N Høiby, B Frederiksen, T Pressler Journal of Cystic Fibrosis 4, 49-54, 2005 | 326 | 2005 |
| Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial F Ratjen, C Hug, G Marigowda, S Tian, X Huang, S Stanojevic, CE Milla, ... The lancet Respiratory medicine 5 (7), 557-567, 2017 | 318 | 2017 |
| Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience CR Hansen, T Pressler, N Høiby Journal of Cystic Fibrosis 7 (6), 523-530, 2008 | 258 | 2008 |
| The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type C Moser, S Kjaergaard, T Pressler, A Kharazmi, C Koch, N Høiby Apmis 108 (5), 329-335, 2000 | 215 | 2000 |
| Chronic Pseudomonas aeruginosa infection definition: EuroCareCF working group report T Pressler, C Bohmova, S Conway, S Dumcius, L Hjelte, N Høiby, ... Journal of Cystic Fibrosis 10, S75-S78, 2011 | 203 | 2011 |
| Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance KL Mortensen, RH Jensen, HK Johansen, M Skov, T Pressler, SJ Howard, ... Journal of clinical microbiology 49 (6), 2243-2251, 2011 | 196 | 2011 |
| Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients HK Johansen, SM Moskowitz, O Ciofu, T Pressler, N Høiby Journal of Cystic Fibrosis 7 (5), 391-397, 2008 | 191 | 2008 |
| Understanding the natural progression in% FEV1 decline in patients with cystic fibrosis: a longitudinal study D Taylor-Robinson, M Whitehead, F Diderichsen, HV Olesen, T Pressler, ... Thorax 67 (10), 860-866, 2012 | 187 | 2012 |
| Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients CR Hansen, T Pressler, KG Nielsen, PØ Jensen, T Bjarnsholt, N Høiby Journal of Cystic Fibrosis 9 (1), 51-58, 2010 | 181 | 2010 |
| Effect of aerosolized rhDNase (Pulmozyme®) on pulmonary colonization in patients with cystic fibrosis B Frederiksen, T Pressler, A Hansen, C Koch, N Høiby Acta Paediatrica 95 (9), 1070-1074, 2006 | 162 | 2006 |
| Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study CR Hansen, T Pressler, C Koch, N Høiby Journal of Cystic Fibrosis 4 (1), 35-40, 2005 | 159 | 2005 |
| Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial BM Assael, T Pressler, D Bilton, M Fayon, R Fischer, R Chiron, M LaRosa, ... Journal of Cystic fibrosis 12 (2), 130-140, 2013 | 157 | 2013 |
| Mannose‐binding lectin (MBL) therapy in an MBL‐deficient patient with severe cystic fibrosis lung disease P Garred, T Pressler, S Lanng, HO Madsen, C Moser, I Laursen, ... Pediatric pulmonology 33 (3), 201-207, 2002 | 143 | 2002 |
| Serial lung function and responsiveness in cystic fibrosis during early childhood KG Nielsen, T Pressler, B Klug, C Koch, H Bisgaard American journal of respiratory and critical care medicine 169 (11), 1209-1216, 2004 | 138 | 2004 |
| Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis T Qvist, D Taylor-Robinson, E Waldmann, HV Olesen, CR Hansen, ... Journal of Cystic Fibrosis 15 (3), 380-385, 2016 | 135 | 2016 |
